Attached files
| file | filename |
|---|---|
| 8-K - 8-K - Biostage, Inc. | tm2117804d1_8k.htm |
Exhibit 16.1
May 27, 2021
Securities and Exchange Commission Washington, D.C. 20549
|
 |
Commissioners:
We have read Biostage, Inc.’s statements included under Item 4.01(a) of its Form 8-K filed on May 27, 2021 and we agree with such statements concerning our firm.
/s/ RSM US LLP